Ruti Aga's Six-Year Ban: A Forged Prescription, a Clinic That Never Existed, and the Arithmetic Behind the Sanction

The clinic on the letterhead did not exist. The man who signed the prescription was family, not a registered medical practitioner. Under questioning he said he had used "an old prescription pad from a former workplace" — and the clinic later disowned the pad entirely. Three independent verification failures on a single sheet of paper. The Athletics Integrity Unit (AIU) ruling issued on Thursday comes down to that: the sanction here sits on the paperwork, not on the drug. Ethiopian marathoner Ruti Aga is banned for six years, counted from 10 September — two years for presence of a prohibited substance, four for tampering. A false-start column tells you at a glance that the race ended before it began. The prescription does the same.

Ruti Aga, 32. She belongs to the Ethiopian marathon generation that rewired the economics of road racing over the past decade: second at Berlin 2026 in 2:18:34, champion at Tokyo 2026 in 2:20:40, three second-place finishes at World Marathon Majors. The first line of any results sheet should also say this — zero World Championships or Olympic medals. That is the unit the rest of the audit rests on.

The case, then. After winning a half marathon in China in March, Aga's sample returned methylprednisolone. Her explanation: treatment for a knee injury. She submitted a prescription. The AIU found it forged. She had been provisionally suspended from 10 September; the same date starts the ban. The source does not state the ban's end date.

There is a technical detail without which nothing here makes sense. In road racing, the in-competition testing window opens at 23:59 the day before the race. A knee injection given days earlier is therefore caught. The same injection is entirely legal out-of-competition; its residue in-competition makes it a violation. The whole case hinges on route and timing, not on the name of the substance.

In sports medicine, a glucocorticoid has a plain job: suppress inflammation and push the pain threshold upward. In a race where appearance money arrives at the start line and prize money at the finish, a knee that wants four weeks of rest is the most expensive injury an athlete can carry. That is why the injection gets taken — and why this case moves past one athlete's judgement into the supply chain around her.

What the source omits is also information. No mark is given for the Chinese half marathon, no splits, no field depth, no year for March. Where there is no measurement, inferring form is fabrication. All we have is this: she won, and the sample followed the win. In this story the performance is secondary; the disqualification is the story.

The drug class, and the reporting error

Reports calling this a "prohibited steroid" are wrong on the chemistry and therefore misleading on the law. Methylprednisolone is a glucocorticoid, class S9 of the WADA Prohibited List, not an anabolic steroid under S1. S9 substances are prohibited in-competition only, and only by injection, oral or rectal routes. Put the steroid lens on the case and it becomes a fraud story; put the glucocorticoid lens on it and it becomes a question of timing and route. Aga had a legitimate defence available, and the forged prescription is what destroyed it.

Two plus four equals six

The sum is not evidence of AIU severity; it is standard Code arithmetic. For presence of a Specified Substance without proven intent, the standard sanction is two years, reducible to a reprimand if an athlete establishes no significant fault. For tampering, the Code's standard sanction is four years. The real question therefore is not why six, but why the presence charge stayed at two — because two means the panel did not accept the mitigation that genuine medical records would have supported. Forged documents are themselves circumstantial evidence of concealment, yet they did not escalate the presence sanction; the panel treated presence as proven without aggravating intent, and tampering as fully culpable. The arithmetic is internally clean.

A plausible knee, a fatal pad

Intra-articular methylprednisolone for knee synovitis is textbook practice in distance running. The mechanism is plausible — and that plausibility is exactly what makes the forgery fatal. A real treatment would have been defended with real records. Three independent verifications failed at once: no clinic, no registered signatory, no pad. Plausibility without paper is not a defence; it becomes evidence. A TUE pathway existed; a washout calculation existed; neither was used. The four years did not come from the document alone but from statements made under questioning. A CAS appeal window normally runs about 21 days from the reasoned decision; a documentary forgery finding is hard to overturn.

The institution that was missing

What matters most here is not who lied but that there was no team physician at all. No TUE application, no washout arithmetic, no registered doctor. In the East African road-racing model, an athlete's real employer is the agent and the informal staff, not an institution. Compare India: Railways, Services and SAI camps provide medical cover, however imperfect. In the Tokyo 2026 mixed zone I spent two days with the men's 4x400 squad, and it was clear the baton losses were a coaching-market failure rather than a talent failure; with Aga the order is the same. Staffing failure first, character failure second. Twenty-six years of reading this sport off results sheets leaves exactly one usable line here — the date from which the counting starts.

Appearance fees and testing, colliding

The Chinese label circuit is a lucrative, low-race-count income tier for East African marathoners between Majors. That same tier has become the AIU's highest-yield testing ground. Two economies are colliding inside the same race: the appearance-fee economy and the testing economy. The race she won is the reason she was catchable. At Kalinga I counted strides before I counted medals; for this story I had to count years.

What gets struck, what survives

The source does not state the disqualification's scope, and that is a gap. Standard AIU practice is straightforward: the result and prize money of the competition where the sample was collected are annulled. The March win, its money and ranking points accrued after it will go. What does not go is the 2026 Tokyo title — absent a finding of earlier use, results before the violation date are not automatically erased. The dead-ball ledger never lies; live play just distracts. The broadcast carries the ban; the record book will still show Tokyo and will no longer show March.

From 32 to 38

Six years from 10 September puts any return at roughly 38. Ethiopian women's marathon depth is world-record class, where sub-2:12 exists and a 2:18 performer is not automatically selectable. In that pool, a 38-year-old returnee carrying a doping record is not a selection debate. The ban is six years on paper and a career on the ground. The national team is untouched: her three Major podiums were commercial-tier results, not championship conversions. The peak was never the point; the population beneath it is.

There are two easy readings of this decision, and both miss. One: the AIU is rigorous, fearless, a deterrent. Two: disproportionate enforcement against African road runners — six years for a substance with no proven endurance benefit. Both fail at the same spot: the six years are not a drug sanction, they are a document sanction. From there comes the uncomfortable finding — the more credible the medical story, the more lethal the forgery. If the knee treatment was true, the truth killed her, because the only way to prove it ran through records, not a pad.

The second uncomfortable finding is that the enforcement frontier has moved. This case begins with a sample and ends in an interview. Athletes' own words are now exhibits. Language and translation conditions in AIU interviews with Ethiopian athletes have been a recurring point of contention; that is not an excuse, it is an audit item. And a comparison I keep making in this trade: referees never explain a decision inside the stadium, leaving fans as the ignored audience, while the AIU at least leaves a written decision you can count. Here, at minimum, the arithmetic can be demanded.

The question is not who gets caught next. Informal medical networks in East African road racing serve training clusters, not individuals, so the next case is already in the queue, unnamed. The Ethiopian federation has said nothing; only the AIU is quoted. Every shutdown invents a quota economy, and every quota economy hides a queue — here the queue is a list of names that will surface the same way within two years. The real question is whose name goes on the entry list before the entry list itself: the doctor's or the prescription pad's. The day road racing's entourages get licensed, cases like this will thin out. It is a cheaper bargain than six years.